Cancer specialists debate when to retreat previously irradiated tumors

A new analysis in the International Journal of Radiation Oncology examines the clinical case for re-treating cancer patients who have already received radiation—a decision that affects treatment planning, patient outcomes, and healthcare resource allocation. The findings could reshape protocols for managing recurrent tumors in breast cancer, myeloma, and other malignancies.

Originaltitel: To Reirradiate or Not to Reirradiate—That Is the Question